rs376676328

Variant summary

Our verdict is Uncertain significance. The variant received -3 ACMG points: 1P and 4B. BP2_StrongPP3

This summary comes from the ClinGen Evidence Repository: The ATM c.8734A>G (p.Arg2912Gly) variant is predicted deleterious by multiple protein in silico tools (PP3). This variant has been observed in a compound heterozygous state (presumed) in multiple individuals without Ataxia-Telangiectasia (BP2_Strong, GTR Lab IDs: 61756, 500031, <-4.0 POINTS). In summary, this variant meets criteria to be classified as uncertain significance based on the ACMG/AMP criteria applied as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA157198/MONDO:0016419/020

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 1 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

13
5

Clinical Significance

Uncertain significance reviewed by expert panel U:27B:3O:2

Conservation

PhyloP100: 3.98

Publications

33 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received -3 ACMG points.

PP3
For more information check the summary or visit ClinGen Evidence Repository.
BP2
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.8734A>Gp.Arg2912Gly
missense
Exon 60 of 63NP_000042.3
ATM
NM_001351834.2
c.8734A>Gp.Arg2912Gly
missense
Exon 61 of 64NP_001338763.1Q13315
C11orf65
NM_001330368.2
c.640+32092T>C
intron
N/ANP_001317297.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.8734A>Gp.Arg2912Gly
missense
Exon 60 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.8734A>Gp.Arg2912Gly
missense
Exon 61 of 64ENSP00000388058.2Q13315
C11orf65
ENST00000615746.4
TSL:1
c.*1196+1087T>C
intron
N/AENSP00000483537.1Q8NCR3-1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152176
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000219
AC:
55
AN:
251450
AF XY:
0.000235
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000413
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000183
AC:
267
AN:
1461760
Hom.:
1
Cov.:
31
AF XY:
0.000198
AC XY:
144
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000345
AC:
9
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86254
European-Finnish (FIN)
AF:
0.000168
AC:
9
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000210
AC:
233
AN:
1111908
Other (OTH)
AF:
0.000232
AC:
14
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152294
Hom.:
0
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41550
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000367
AC:
25
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000187
Hom.:
0
Bravo
AF:
0.000170
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.000491
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
7
-
not provided (7)
-
5
1
Hereditary cancer-predisposing syndrome (6)
-
5
-
Ataxia-telangiectasia syndrome (5)
-
3
1
Familial cancer of breast (4)
-
3
-
not specified (4)
-
1
-
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast (2)
-
1
-
ATM-related cancer predisposition (1)
-
1
-
ATM-related disorder (1)
-
1
-
Breast and/or ovarian cancer (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.66
D
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D
M_CAP
Pathogenic
0.52
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Uncertain
0.71
D
MutationAssessor
Pathogenic
3.3
M
PhyloP100
4.0
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-5.8
D
REVEL
Pathogenic
0.88
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.97
MVP
0.96
MPC
0.66
ClinPred
0.78
D
GERP RS
5.4
Varity_R
0.92
gMVP
0.92
Mutation Taster
=4/96
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376676328; hg19: chr11-108224555; API